A-101 Solution 40%

· Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A-101 Solution 40%, covering 2017-11-13 to 2017-11-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. [Phase 3]